Lidokain/Adrenalin Aguettant (Epinephrine, Lidocaine Hydrochloride)

Lidocaine hydrochloride blocks voltage‑gated sodium channels on nerve membranes, preventing the initiation and propagation of action potentials. This inhibition stops nerve impulse transmission, resulting in loss of sensation in the targeted area.

The specific dose of Lidokain/Adrenalin is determined by the prescribing clinician based on the procedure, patient characteristics, and route of administration. Only a qualified health professional should set the dosage and administration schedule.

Safety data for Lidokain/Adrenalin in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lidokain/Adrenalin combines lidocaine with epinephrine, which causes local vasoconstriction. This prolongs the anesthetic effect, reduces systemic absorption, and can decrease intra‑operative bleeding compared with lidocaine alone, making it useful for procedures where a longer duration of action is desired.

Store the product at room temperature, preferably below 25 °C, in its original packaging. Protect it from direct sunlight, moisture, and extreme temperatures. Do not freeze the solution, and keep it out of reach of children.

Lidokain/Adrenalin is administered by a qualified health professional via injection. It can be given epidurally, infiltratively, or perineurally, depending on the clinical indication and the targeted anatomical site.

Serious risks include severe allergic reactions (anaphylaxis), cardiac arrhythmias, seizures, and methemoglobinemia. Patients should be monitored for signs of toxicity, especially when high doses are used or when administered near highly vascular areas.

Individuals with a known hypersensitivity to lidocaine, epinephrine, or any component of the formulation should avoid this product. Caution is also advised for patients with severe cardiac disease, uncontrolled hypertension, or certain metabolic disorders, as determined by the prescribing clinician.